Clinical Trial Update: Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Update on a Visilizumab trial in severe ulcerative colitis spanning Phase 1 and Phase 2, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Visilizumab (visilizumab)

Snippet

Sponsor: Facet Biotech | Conditions: Severe Ulcerative Colitis | Phase 1, Phase 2 | Status: COMPLETED